v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Previously reported
Previously reported
Common Stock
Previously reported
Additional Paid-in Capital
Previously reported
Accumulated Deficit
Previously reported
Accumulated Other Comprehensive Income (Loss)
Retroactive application of recapitalization
Retroactive application of recapitalization
Common Stock
Retroactive application of recapitalization
Additional Paid-in Capital
Beginning balance (in shares) at Dec. 31, 2020   44,461         9,750         34,711  
Beginning balance at Dec. 31, 2020 $ 24,766 $ 4 $ 45,890 $ (21,128) $ 0 $ (20,441) $ 1 $ 686 $ (21,128) $ 0 $ 45,207 $ 3 $ 45,204
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Business Combination and PIPE Shares, net (in shares)   53,361                      
Business Combination and PIPE shares, net 433,527 $ 6 433,521                    
Conversion of Private Warrants 5,819   5,819                    
Stock option exercise (in shares)   103                      
Stock option exercise 35   35                    
Stock-based compensation 6,287   6,287                    
Net loss (28,515)     (28,515)                  
Other comprehensive income (loss) (669)       (669)                
Ending balance (in shares) at Mar. 31, 2021   97,925                      
Ending balance at Mar. 31, 2021 441,250 $ 10 491,552 (49,643) (669)                
Beginning balance (in shares) at Dec. 31, 2020   44,461         9,750         34,711  
Beginning balance at Dec. 31, 2020 24,766 $ 4 45,890 (21,128) 0 $ (20,441) $ 1 $ 686 $ (21,128) $ 0 $ 45,207 $ 3 $ 45,204
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (77,799)                        
Other comprehensive income (loss) (2,578)       (2,578)                
Ending balance (in shares) at Sep. 30, 2021   100,674                      
Ending balance at Sep. 30, 2021 465,440 $ 10 566,935 (98,927) (2,578)                
Beginning balance (in shares) at Mar. 31, 2021   97,925                      
Beginning balance at Mar. 31, 2021 441,250 $ 10 491,552 (49,643) (669)                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Conversion of Private Warrants 3,114   3,114                    
Issuance of common stock for acquisition of Root AI (in shares)   2,329                      
Issuance of common stock for acquisition of Root AI 48,991   48,991                    
Issuance of stock options for business combination 361   361                    
Vesting of restricted stock units (in shares)   21                      
Vesting of restricted stock units (108)   (108)                    
Stock-based compensation 13,390   13,390                    
Net loss (32,016)     (32,016)                  
Other comprehensive income (loss) (1,843)       (1,843)                
Ending balance (in shares) at Jun. 30, 2021   100,275                      
Ending balance at Jun. 30, 2021 473,139 $ 10 557,300 (81,659) (2,512)                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Conversion of Private Warrants 201   201                    
Vesting of restricted stock units (in shares)   391                      
Vesting of restricted stock units (2,233)   (2,233)                    
Warrants exercised (in shares)   8                      
Warrants exercised 96   96                    
Stock-based compensation 11,571   11,571                    
Net loss (17,268)     (17,268)                  
Other comprehensive income (loss) (66)       (66)                
Ending balance (in shares) at Sep. 30, 2021   100,674                      
Ending balance at Sep. 30, 2021 465,440 $ 10 566,935 (98,927) (2,578)                
Beginning balance (in shares) at Dec. 31, 2021   101,136                      
Beginning balance at Dec. 31, 2021 387,640 $ 10 576,895 (187,314) (1,951)                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Conversion of Private Warrants 1,104   1,104                    
Stock option exercise 36   36                    
Vesting of restricted stock units (in shares)   414                      
Vesting of restricted stock units (953)   (953)                    
Stock-based compensation 6,035   6,035                    
Net loss (30,635)     (30,635)                  
Other comprehensive income (loss) 4,360       4,360                
Ending balance (in shares) at Mar. 31, 2022   101,550                      
Ending balance at Mar. 31, 2022 367,587 $ 10 583,117 (217,949) 2,409                
Beginning balance (in shares) at Dec. 31, 2021   101,136                      
Beginning balance at Dec. 31, 2021 387,640 $ 10 576,895 (187,314) (1,951)                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (83,324)                        
Other comprehensive income (loss) 10,671       10,671                
Ending balance (in shares) at Sep. 30, 2022   107,278                      
Ending balance at Sep. 30, 2022 343,315 $ 11 605,222 (270,638) 8,720                
Beginning balance (in shares) at Mar. 31, 2022   101,550                      
Beginning balance at Mar. 31, 2022 367,587 $ 10 583,117 (217,949) 2,409                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock option exercise (in shares)   762                      
Stock option exercise 22   21                    
Issuance of common stock under the Purchase Agreement (in shares)   3,150                      
Issuance of common stock under the Purchase Agreement 8,232   8,232                    
Issuance of common stock for Employee Stock Purchase Plan (in shares)   78                      
Issuance of common stock for Employee Stock Purchase Plan 211   211                    
Vesting of restricted stock units (in shares)   197                      
Vesting of restricted stock units (369)   (369)                    
Stock-based compensation 5,993   5,993                    
Net loss (28,705)     (28,705)                  
Other comprehensive income (loss) 2,760       2,760                
Ending balance (in shares) at Jun. 30, 2022   105,737                      
Ending balance at Jun. 30, 2022 355,731 $ 11 597,205 (246,654) 5,169                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock option exercise (in shares)   338                      
Stock option exercise 80   80                    
Issuance of common stock under the Purchase Agreement (in shares)   360                      
Issuance of common stock under the Purchase Agreement 1,298   1,298                    
Issuance of common stock, net (in shares)   542                      
Issuance of common stock, net 1,347   1,347                    
Vesting of restricted stock units (in shares)   301                      
Vesting of restricted stock units (175)   (175)                    
Stock-based compensation 5,467   5,467                    
Net loss (23,984)     (23,984)                  
Other comprehensive income (loss) 3,551       3,551                
Ending balance (in shares) at Sep. 30, 2022   107,278                      
Ending balance at Sep. 30, 2022 $ 343,315 $ 11 $ 605,222 $ (270,638) $ 8,720